Page last updated: 2024-09-03

celastrol and lactacystin

celastrol has been researched along with lactacystin in 3 studies

Compound Research Comparison

Studies
(celastrol)
Trials
(celastrol)
Recent Studies (post-2010)
(celastrol)
Studies
(lactacystin)
Trials
(lactacystin)
Recent Studies (post-2010) (lactacystin)
88517419201155

Protein Interaction Comparison

ProteinTaxonomycelastrol (IC50)lactacystin (IC50)
Proteasome subunit beta type-11Homo sapiens (human)0.259
Proteasome subunit alpha type-7Homo sapiens (human)0.259
Proteasome subunit beta type-1Homo sapiens (human)0.259
Proteasome subunit alpha type-1Homo sapiens (human)0.259
Proteasome subunit alpha type-2Homo sapiens (human)0.259
Proteasome subunit alpha type-3Homo sapiens (human)0.259
Proteasome subunit alpha type-4Homo sapiens (human)0.259
Proteasome subunit beta type-8Homo sapiens (human)0.259
Proteasome subunit beta type-9Homo sapiens (human)0.259
Proteasome subunit alpha type-5Homo sapiens (human)0.259
Proteasome subunit beta type-4Homo sapiens (human)0.259
Proteasome subunit beta type-6Homo sapiens (human)0.259
Proteasome subunit beta type-5Homo sapiens (human)1.2498
Proteasome subunit beta type-10Homo sapiens (human)0.259
Proteasome subunit beta type-3Homo sapiens (human)0.259
Proteasome subunit beta type-2Homo sapiens (human)1.7545
Proteasome subunit alpha type-6Homo sapiens (human)0.259
Splicing factor 3B subunit 3Homo sapiens (human)3.481
Proteasome subunit alpha-type 8Homo sapiens (human)0.259
Proteasome subunit beta type-7Homo sapiens (human)0.259

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, D; Dou, QP; Landis-Piwowar, KR; Milacic, V; Yang, H1
Jantas, D; Konieczny, J; Kuśmierczyk, J; Lasoń, W; Lenda, T; Lorenc-Koci, E; Roman, A1
Czarnecka, A; Domin, H; Jantas, D; Konieczny, J; Kuter, K; Lasoń, W; Lenda, T; Lorenc-Koci, E; Śmiałowska, M1

Reviews

1 review(s) available for celastrol and lactacystin

ArticleYear
Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.
    Current protein & peptide science, 2008, Volume: 9, Issue:3

    Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Clinical Trials as Topic; Curcumin; Humans; Neoplasms; Pentacyclic Triterpenes; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Triterpenes; Ubiquitin

2008

Other Studies

2 other study(ies) available for celastrol and lactacystin

ArticleYear
The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.
    Neurotoxicity research, 2013, Volume: 24, Issue:1

    Topics: Acetylcysteine; Cell Death; Cell Differentiation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Interactions; Humans; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Pentacyclic Triterpenes; Rotenone; Time Factors; Tretinoin; Triterpenes

2013
Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease.
    Neurotoxicity research, 2014, Volume: 26, Issue:3

    Topics: Acetylcysteine; Animals; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cerebral Cortex; Corpus Striatum; Dopamine; Humans; Male; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Parkinson Disease; Pentacyclic Triterpenes; Proteasome Inhibitors; Rats; Rats, Wistar; Substantia Nigra; Triterpenes

2014